Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Blood|January 16, 2009
Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cellsMotoko Koyama, Daigo Hashimoto, Kazutoshi Aoyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2020
[Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease]Shuki Oya, Yoshitaka Yamasaki, Takayuki Nakamura, et al.
Odontology|November 15, 2011
Histological and immunohistochemical features of gingival enlargement in a patient with AMLNorihiro Sonoi, Yoshihiko Soga, Hiroshi Maeda, et al.
International Journal of Hematology|July 4, 2024
High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemiaShuki Oya, Hidetoshi Ozawa, Satoshi Morishige, et al.
International Journal of Hematology|June 22, 2006
Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantationNobuharu Fujii, Kazuma Ikeda, Motoko Koyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products]Maki Yamaguchi, Yusuke Takaki, Yoshitaka Yamasaki, et al.
International Journal of Hematology|June 2, 2019
Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantationSatoshi Morishige, Marina Nishi, Hiroshi Saruta, et al.
International Journal of Hematology|February 16, 2024
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignanciesTakayuki Nakamura, Shuki Oya, Hidetoshi Ozawa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2020
Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR/Cas9-mediated gene editingTakayuki Nakamura, Satoshi Morishige, Hidetoshi Ozawa, et al.
International Journal of Hematology|June 9, 2024
CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicityShuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, et al.
Pageof 3